TY  - CHAP
M1  - Book, Section
TI  - Osteoporosis MTM Data Set
A1  - Whalen, Karen
A1  - Miller, Shannon A.
A2  - Whalen, Karen
A2  - Hardin, Heather C.
PY  - 2018
T2  - Medication Therapy Management: A Comprehensive Approach, 2e
AB  - KEY  POINTSMedication  therapy  management  (MTM)  providers  should  screen  for  medications  that  are  associated  with  an  increased  risk  of  osteoporosis  and  recommend  bone  mineral  density  testing  to  the  primary  provider,  if  appropriate.Adequate  calcium  and  vitamin  D  intake  is  essential  for  prevention  and  treatment  of  osteoporosis.  An  evaluation  of  dietary  calcium  intake  will  assist  in  determination  of  required  calcium  supplementation.Calcium  carbonate  is  the  salt  of  choice  for  calcium  supplementation  because  it  has  the  highest  percentage  of  elemental  calcium  and  is  the  least  expensive;  however,  calcium  citrate  should  be  considered  for  elderly  patients  with  low  acid  production  or  those  on  acid-reducing  medications.MTM  providers  should  assess  for  appropriate  administration  of  bisphosphonate  therapy  and  counsel  patients  on  the  importance  of  appropriate  administration  to  reduce  adverse  effects  and  maximize  efficacy  of  therapy.Adherence  is  poor  with  bisphosphonate  therapy  and  decreases  efficacy.  MTM  providers  should  screen  for  nonadherence  and  recommend  changes  in  pharmacotherapy  or  other  methods  to  improve  adherence.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1150201504
ER  -